TEVA PHARMACEUTICAL INDUSTRIES LIMITED Revenue from Contract with Customer, Including Assessed Tax
TEVA PHARMACEUTICAL INDUSTRIES LIMITED (TEVJF) reported Revenue from Contract with Customer, Including Assessed Tax of $4.70 billion for the 3-month period ending 2018-06-30, per its 10-Q filed 2018-08-02.
Discontinued › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax · last filed 2018-08-02
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED revenue from contract with customer, including assessed tax for the quarter ending 2018-06-30 was $4.70B, a 17.81% decline year-over-year.
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED revenue from contract with customer, including assessed tax for the quarter ending 2017-06-30 was $5.72B.
| Period end | Revenue from Contract with Customer, Including Assessed Tax 3 month | Revenue from Contract with Customer, Including Assessed Tax 6 month |
|---|---|---|
| 2018-06-30 | $4.70B 10-Q · filed 2018-08-02 | $9.77B 10-Q · filed 2018-08-02 |
| 2017-06-30 | $5.72B 10-Q · filed 2018-08-02 | $11.37B 10-Q · filed 2018-08-02 |